RE:RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an agree okgonow that they will need a lot of flower as international orders increase, but didnt they also pick up an additional growing facility with the Vivo takeover. If I am not mistaken they now have 3 large grow ops.
I dont know what the costs from flower to a finished Dronbinol product is, but Tilray also produces Dronbinol so it could have been a direct $ million dollar product swap to satisfy that portion of the settlement agreement.
Still not certain if the other agreement committment includes a $500k per year over 4 years with Tilray, or a $125K per year supply agreement, but that settlement is coming to fruition.
Hoping Q1 clears a bit of that up, but it appears at least from the outside looking in that getting to profitability for Medipharm is closer with each quarter.......
With it being 4/20 today, what other surprises are in store?